Table 1 Baseline characteristics.
Conventional group (n = 20) | KODEX group (n = 20) | Statistic quantity | P | |
|---|---|---|---|---|
Gender (male) | 15 (75%) | 12 (60%) | 1.026 | 0.311 |
Age (years) | 65.10 ± 10.46 | 69.75 ± 10.66 | 1.392 | 0.172 |
BMI (kg/m2) | 25.65 ± 3.75 | 25.25 ± 2.69 | 0.388 | 0.700 |
Hypertension | 13 (65%) | 12 (60%) | 0.107 | 0.744 |
Diabetes | 3 (15%) | 4 (20%) | 0.173 | 1.000 |
CHD | 8 (40%) | 6 (30%) | 0.440 | 0.507 |
Stroke | 6 (30%) | 2 (10%) | 2.500 | 0.235 |
Heart failure | 1 (5%) | 0 (0%) | 1.026 | 1.000 |
Renal insufficiency | 0 (0%) | 2 (10%) | 2.105 | 0.487 |
Creatinine clearance rate (μmol/l) | 89.52 ± 22.13 | 77.86 ± 16.53 | 1.888 | 0.067 |
CHA2DS2-VASc score | 2.20 ± 1.61 | 2.30 ± 1.46 | 0.206 | 0.838 |
HAS-BLED score | 1.15 ± 0.81 | 1.25 ± 0.64 | 0.433 | 0.668 |
LA (mm) | 40.65 ± 4.92 | 39.85 ± 6.18 | 0.453 | 0.653 |
LV (mm) | 50.10 ± 7.77 | 48.90 ± 7.21 | 0.506 | 0.615 |
LVEF (%) | 58.53 ± 8.14 | 59.50 ± 6.61 | 0.413 | 0.682 |
